Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context
Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hy...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396422005163 |
_version_ | 1811179580407414784 |
---|---|
author | Sören J. Backhaus Harun Uzun Simon F. Rösel Alexander Schulz Torben Lange Richard J. Crawley Ruben Evertz Gerd Hasenfuß Andreas Schuster |
author_facet | Sören J. Backhaus Harun Uzun Simon F. Rösel Alexander Schulz Torben Lange Richard J. Crawley Ruben Evertz Gerd Hasenfuß Andreas Schuster |
author_sort | Sören J. Backhaus |
collection | DOAJ |
description | Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hypothesized comprehensive cardiovascular magnetic resonance (CMR) assessment of cardiac hemodynamic forces (HDF) may identify functional abnormalities in HFpEF. Methods: The HFpEF Stress Trial (DZHK-17; Clinicaltrials.gov: NCT03260621) prospectively recruited 75 patients with exertional dyspnea, preserved EF (≥50%) and signs of diastolic dysfunction (E/e’ ≥8) on echocardiography. Patients underwent rest and exercise-stress right heart catheterisation, echocardiography and CMR. The final study cohort consisted of 68 patients (HFpEF n = 34 and non-cardiac dyspnea n = 34 according to pulmonary capillary wedge pressure (PCWP)). HDF assessment included left ventricular (LV) longitudinal, systolic peak and impulse, systolic/diastolic transition, E-wave deceleration as well as A-wave acceleration forces. Follow-up after 24 months evaluated cardiovascular mortality and hospitalisation (CVH) – only two patients were lost to follow-up. Findings: HDF assessment revealed impairment of LV longitudinal function in patients with HFpEF compared to non-cardiac dyspnoea (15.8% vs. 18.3%, p = 0.035), attributable to impairment of systolic peak (38.6% vs 51.6%, p = 0.003) and impulse (20.8% vs. 24.5%, p = 0.009) forces as well as late diastolic filling (−3.8% vs −5.4%, p = 0.029). Early diastolic filling was impaired in HFpEF patients identified at rest compared with patients identified during stress only (7.7% vs. 9.9%, p = 0.004). Impaired systolic peak was associated with CVH (HR 0.95, p = 0.016), and was superior to LV global longitudinal strain assessment in prediction of CVH (AUC 0.76 vs. 0.61, p = 0.048). Interpretation: Assessment of HDF indicates impairment of LV systolic ejection force in HFpEF which is associated with cardiovascular events. Funding: German Centre for Cardiovascular Research (DZHK). |
first_indexed | 2024-04-11T06:36:36Z |
format | Article |
id | doaj.art-f477abf7c64f440c8921fe18fe24cf54 |
institution | Directory Open Access Journal |
issn | 2352-3964 |
language | English |
last_indexed | 2024-04-11T06:36:36Z |
publishDate | 2022-12-01 |
publisher | Elsevier |
record_format | Article |
series | EBioMedicine |
spelling | doaj.art-f477abf7c64f440c8921fe18fe24cf542022-12-22T04:39:41ZengElsevierEBioMedicine2352-39642022-12-0186104334Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in contextSören J. Backhaus0Harun Uzun1Simon F. Rösel2Alexander Schulz3Torben Lange4Richard J. Crawley5Ruben Evertz6Gerd Hasenfuß7Andreas Schuster8University Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany; School of Biomedical Engineering and Imaging Sciences, King's College London, United KingdomUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanySchool of Biomedical Engineering and Imaging Sciences, King's College London, United KingdomUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, GermanyUniversity Medical Center Göttingen, Department of Cardiology and Pneumology, Georg-August University, Göttingen, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Göttingen, Göttingen, Germany; School of Biomedical Engineering and Imaging Sciences, King's College London, United Kingdom; Corresponding author. University Medical Centre, Georg-August-University Göttingen, Department of Cardiology and Pneumology, Robert-Koch-Str. 40, 37099, Göttingen, Germany.Summary: Background: The diagnosis of heart failure with preserved ejection fraction (HFpEF) remains challenging. Exercise-stress testing is recommended in case of uncertainty; however, this approach is time-consuming and costly. Since preserved EF does not represent normal systolic function, we hypothesized comprehensive cardiovascular magnetic resonance (CMR) assessment of cardiac hemodynamic forces (HDF) may identify functional abnormalities in HFpEF. Methods: The HFpEF Stress Trial (DZHK-17; Clinicaltrials.gov: NCT03260621) prospectively recruited 75 patients with exertional dyspnea, preserved EF (≥50%) and signs of diastolic dysfunction (E/e’ ≥8) on echocardiography. Patients underwent rest and exercise-stress right heart catheterisation, echocardiography and CMR. The final study cohort consisted of 68 patients (HFpEF n = 34 and non-cardiac dyspnea n = 34 according to pulmonary capillary wedge pressure (PCWP)). HDF assessment included left ventricular (LV) longitudinal, systolic peak and impulse, systolic/diastolic transition, E-wave deceleration as well as A-wave acceleration forces. Follow-up after 24 months evaluated cardiovascular mortality and hospitalisation (CVH) – only two patients were lost to follow-up. Findings: HDF assessment revealed impairment of LV longitudinal function in patients with HFpEF compared to non-cardiac dyspnoea (15.8% vs. 18.3%, p = 0.035), attributable to impairment of systolic peak (38.6% vs 51.6%, p = 0.003) and impulse (20.8% vs. 24.5%, p = 0.009) forces as well as late diastolic filling (−3.8% vs −5.4%, p = 0.029). Early diastolic filling was impaired in HFpEF patients identified at rest compared with patients identified during stress only (7.7% vs. 9.9%, p = 0.004). Impaired systolic peak was associated with CVH (HR 0.95, p = 0.016), and was superior to LV global longitudinal strain assessment in prediction of CVH (AUC 0.76 vs. 0.61, p = 0.048). Interpretation: Assessment of HDF indicates impairment of LV systolic ejection force in HFpEF which is associated with cardiovascular events. Funding: German Centre for Cardiovascular Research (DZHK).http://www.sciencedirect.com/science/article/pii/S2352396422005163HFpEFCardiovascular magnetic resonanceHemodynamic forceDeformation imagingStrain |
spellingShingle | Sören J. Backhaus Harun Uzun Simon F. Rösel Alexander Schulz Torben Lange Richard J. Crawley Ruben Evertz Gerd Hasenfuß Andreas Schuster Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context EBioMedicine HFpEF Cardiovascular magnetic resonance Hemodynamic force Deformation imaging Strain |
title | Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context |
title_full | Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context |
title_fullStr | Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context |
title_full_unstemmed | Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context |
title_short | Hemodynamic force assessment by cardiovascular magnetic resonance in HFpEF: A case-control substudy from the HFpEF stress trialResearch in context |
title_sort | hemodynamic force assessment by cardiovascular magnetic resonance in hfpef a case control substudy from the hfpef stress trialresearch in context |
topic | HFpEF Cardiovascular magnetic resonance Hemodynamic force Deformation imaging Strain |
url | http://www.sciencedirect.com/science/article/pii/S2352396422005163 |
work_keys_str_mv | AT sorenjbackhaus hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT harunuzun hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT simonfrosel hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT alexanderschulz hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT torbenlange hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT richardjcrawley hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT rubenevertz hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT gerdhasenfuß hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext AT andreasschuster hemodynamicforceassessmentbycardiovascularmagneticresonanceinhfpefacasecontrolsubstudyfromthehfpefstresstrialresearchincontext |